Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Farrell

Showing results (21-30 of 172) with videos related to

Pageof 18
Sort By:
International Journal of Antimicrobial Agents|December 3, 2010
Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009)Helio S Sader, David J Farrell, Ronald N Jones
Annals of Clinical Microbiology and Antimicrobials|January 15, 2008
Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4Stephen G Jenkins, Steven D Brown, David J Farrell
Diagnostic Microbiology and Infectious Disease|January 22, 2011
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009)Helio S Sader, David J Farrell, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococciDavid J Farrell, Kevin M Krause, Bret M Benton
International Journal of Antimicrobial Agents|April 19, 2011
Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: an 11-year report from the SENTRY Antimicrobial Surveillance ProgramRonald N Jones, David J Farrell, Helio S Sader
Antimicrobial Agents and Chemotherapy|April 7, 2010
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infectionsDavid J Farrell, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|May 7, 2010
Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centresHelio S Sader, David J Farrell, Ronald N Jones
Antimicrobial Agents and Chemotherapy|September 4, 2014
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitalsMariana Castanheira, Janet C Mills, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage studyDavid J Farrell, Marion Robbins, William Rhys-Williams, et al.
Diagnostic Microbiology and Infectious Disease|July 24, 2012
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trialDavid J Farrell, Lisa L Turner, Mariana Castanheira, et al.
Pageof 18

Showing results (21-30 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Antimicrobial Agents|December 3, 2010
Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009)Helio S Sader, David J Farrell, Ronald N Jones
Annals of Clinical Microbiology and Antimicrobials|January 15, 2008
Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4Stephen G Jenkins, Steven D Brown, David J Farrell
Diagnostic Microbiology and Infectious Disease|January 22, 2011
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009)Helio S Sader, David J Farrell, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococciDavid J Farrell, Kevin M Krause, Bret M Benton
International Journal of Antimicrobial Agents|April 19, 2011
Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: an 11-year report from the SENTRY Antimicrobial Surveillance ProgramRonald N Jones, David J Farrell, Helio S Sader
Antimicrobial Agents and Chemotherapy|April 7, 2010
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infectionsDavid J Farrell, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|May 7, 2010
Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centresHelio S Sader, David J Farrell, Ronald N Jones
Antimicrobial Agents and Chemotherapy|September 4, 2014
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitalsMariana Castanheira, Janet C Mills, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage studyDavid J Farrell, Marion Robbins, William Rhys-Williams, et al.
Diagnostic Microbiology and Infectious Disease|July 24, 2012
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trialDavid J Farrell, Lisa L Turner, Mariana Castanheira, et al.
Pageof 18